Hospital Royo Villanova-ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2024

  1. ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

    Endocrine-related cancer

  2. Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 458-466

  3. Glucose metabolism outcomes after pituitary surgery in patients with acromegaly

    Pituitary, Vol. 27, Núm. 5, pp. 497-506

  4. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

    Endocrine-Related Cancer, Vol. 31, Núm. 7

2023

  1. An Integrated CT and MRI Imaging Model to Differentiate between Adrenal Adenomas and Pheochromocytomas

    Cancers, Vol. 15, Núm. 14

  2. Differences in intraoperative and surgical outcomes between normotensive pheochromocytomas and sympathetic paragangliomas (PPGLs) and hypertensive PPGLs: results from the PHEO-RISK STUDY

    Journal of Endocrinological Investigation, Vol. 46, Núm. 4, pp. 805-814

2022

  1. Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas

    Endocrine-related cancer, Vol. 29, Núm. 12, pp. 645-655

2021

  1. Risk factors for intraoperative complications in pheochromocytomas

    Endocrine-Related Cancer, Vol. 28, Núm. 11, pp. 695-703

  2. Surgical outcomes in the pheochromocytoma surgery. Results from the PHEO-RISK STUDY

    Endocrine, Vol. 74, Núm. 3, pp. 676-684

2020

  1. SEEN guidelines for the management and prevention of acute adrenal insufficiency

    Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 1, pp. 53-60